Connect with us

Health

Has The Market Overpriced Moderna’s Vaccine? – Forbes

Moderna stock has jumped by about 4x this year adding over $20 billion in market value, as investors bet that a successful Covid-19 vaccine could generate windfall profits for the clinical-stage biotech company. Is this jump in valuation warranted? We don’t t…

Published

on

ADVERTISEMENT

Medical syringe is seen with Moderna company logo displayed on a screen in the background in this ……

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending